PHK
CLVS

Point72 Hong Kong’s Clovis Oncology, Inc. CLVS Stock Holding History

Point72 Hong Kong’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,267
Closed -$2K – 2570
2022
Q2 		$2K Sell
1,267
-13,936
-92% -$20.6K ﹤0.01% 1801
2022
Q1 		$31K Sell
15,203
-8,420
-36% -$16.5K ﹤0.01% 1455
2021
Q4 		$64K Buy
+23,623
New +$87.3K ﹤0.01% 1281
2020
Q4 		– Sell
-14,907
Closed -$87K – 2136
2020
Q3 		$87K Buy
14,907
+14,526
+3,813% +$86.9K 0.01% 588
2020
Q2 		$3K Sell
381
-898
-70% -$6.8K ﹤0.01% 1065
2020
Q1 		$8K Buy
+1,279
New +$10.3K ﹤0.01% 726
2019
Q4 		– Sell
-12,029
Closed -$47K – 1537
2019
Q3 		$47K Buy
+12,029
New +$97.3K 0.01% 593
2019
Q2 		– Sell
-1,457
Closed -$36K – 1488
2019
Q1 		$36K Buy
1,457
+1,429
+5,104% +$35.8K 0.01% 582
2018
Q4 		$1K Sell
28
-2,568
-99% -$52.5K ﹤0.01% 837
2018
Q3 		$76K Buy
+2,596
New +$101K 0.03% 397
2018
Q2 		– Sell
-117
Closed -$6K – 1274
2018
Q1 		$6K Sell
117
-242
-67% -$14.1K ﹤0.01% 732
2017
Q4 		$24K Buy
+359
New +$25.1K 0.02% 336
2017
Q3 		– Sell
-7
Closed -$1K – 1132
2017
Q2 		$1K Buy
+7
New +$428 ﹤0.01% 759

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Hong Kong's CLVS Position: Q3 2022 in Review

Point72 Hong Kong sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 1,267 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in CLVS in Q2 2017 and held it in 13 quarters. The position peaked at $87K in Q3 2020. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Point72 Hong Kong reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,267 Clovis Oncology, Inc. shares in Q3 2022, an estimated $2K.
  • Point72 Hong Kong first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 13 quarters.
  • Point72 Hong Kong's Clovis Oncology, Inc. position peaked at $87K in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.